In addition, while cancer-associated point mutations in the TP53 gene are equally common in both lumenal and basal-like breast cancers, truncating mutations and large scale deletions in this gene are more prevalent in basal-like breast cancers compared with the lumenal subtypes suggesting that different cell types within mammary epithelia may have different requirements for TP536. The gene discussed is TP53; the disease is cancer.